| Jan 15, 2025 |
Jan 17, 2025 |
Mersana Therapeutics, Inc.
|
CFO |
Sell |
37.5
|
-8,470
|
-6.52%
|
✓
|
$4.9K |
| Jan 14, 2025 |
Jan 16, 2025 |
Mersana Therapeutics, Inc.
|
CFO |
Sell |
46.3
|
-2,331
|
-2.09%
|
✓
|
$1.5K |
| Jan 13, 2025 |
Jan 15, 2025 |
Mersana Therapeutics, Inc.
|
CFO |
Sell |
42.5
|
-3,713
|
-3.41%
|
✓
|
$2.5K |
| Oct 1, 2024 |
Oct 7, 2024 |
Mersana Therapeutics, Inc.
|
CFO |
Sell |
28.8
|
-13,687
|
-12.61%
|
✓
|
$27.2K |
| Jan 13, 2024 |
Jan 17, 2024 |
Mersana Therapeutics, Inc.
|
CFO |
Sell |
28.8
|
-9,327
|
-14.61%
|
✓
|
$25.3K |
| Jan 14, 2023 |
Jan 18, 2023 |
Mersana Therapeutics, Inc.
|
CFO |
Sell |
46.3
|
-5,131
|
-13.53%
|
✗
|
$29.5K |
| Jan 15, 2021 |
Jan 20, 2021 |
Mersana Therapeutics, Inc.
|
Sr. VP., FIN, Product Strategy |
Sell |
46.3
|
-1,162
|
-15.32%
|
✗
|
$24.5K |